<?xml version="1.0" encoding="UTF-8"?>
<p>Essential oil extracted from fructus 
 <italic>Alpinia zerumbet</italic> (EOFAZ) [
 <xref rid="B46" ref-type="bibr">46</xref>] changes the expression of ICAM-1 and VCAM-1 and promotes the adhesion of inflammatory cells. Target genes [
 <xref rid="B47" ref-type="bibr">47</xref>] for NF-
 <italic>Îº</italic>B include ICAM-1 and VCAM-1. Atherosclerosis is characterized by chronic systemic inflammation and the formation of large and medium-sized atherosclerotic plaques. The amelioration of inflammation plays an important role in the treatment of this disease [
 <xref rid="B48" ref-type="bibr">48</xref>, 
 <xref rid="B49" ref-type="bibr">49</xref>]. Endothelial cells can promote the adhesion of inflammatory cells by changing the expression of ICAM-1 and VCAM-1 [
 <xref rid="B50" ref-type="bibr">50</xref>], which is believed to play an important role in the occurrence of inflammation and the pathogenesis of atherosclerosis [
 <xref rid="B51" ref-type="bibr">51</xref>]. EOFAZ may serve as a new drug source for the treatment of atherosclerosis.
</p>
